NanoEcho Investor Relations Material

NanoEcho is a Swedish medical technology company specializing in the development of diagnostic imaging solutions focused on cancer detection. The company is developing an advanced imaging system using magnetic nanoparticles to enhance the accuracy of detecting cancerous tissues, particularly for rectal cancer diagnostics. NanoEcho’s technology aims to provide non-invasive, precise imaging to improve diagnostic outcomes and patient care. Targeting healthcare providers, the company’s innovations are designed to aid in early cancer detection and streamline the diagnostic process. NanoEcho is headquartered in Lund, Sweden, and its shares are listed on the Stockholm Stock Exchange.